Chemical Compound

methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

CAS Registry Number 1258226-87-7
返回搜索 申请报价
methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate 结构式
Primary record

methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate

库存
9,320 克
纯度
98.5 %
CAS
1258226-87-7

化合物标识与属性

CAS
1258226-87-7
PubChem CID
54767916
SMILES
CC(C)[C@@H](C(=O)N1CCC[C@H]1C(=O)NC2=CC=C(C=C2)[C@@H]3CC[C@H](N3C4=CC=C(C=C4)C(C)(C)C)C5=CC=C(C=C5)NC(=O)[C@@H]6CCCN6C(=O)[C@H](C(C)C)NC(=O)OC)NC(=O)OC
Canonical SMILES
COC(=O)N[C@H](C(=O)N1CCC[C@H]1C(=O)Nc1ccc([C@@H]2CC[C@@H](c3ccc(NC(=O)[C@@H]4CCCN4C(=O)[C@@H](NC(=O)OC)C(C)C)cc3)N2c2ccc(C(C)(C)C)cc2)cc1)C(C)C

名称与同义词

  • Ombitasvir
  • ombitasvirum
  • ABT-267
  • 1258226-87-7
  • Ombitasvir [INN]
  • ombitasvir hydrate
  • Ombitasvir(ABT-267)
  • Ombitasvir [USAN:INN]
  • ABT267
  • OMBITASVIR [MI]
  • HCV therapeutic, Abbott
  • Ombitasvir heminonahydrate
  • Ombitasvir (USAN/INN)
  • RefChem:168187
  • OMBITASVIR [USAN]
  • Ombitasvir (ABT-267)
  • OMBITASVIR [VANDF]
  • CHEBI:85183
  • D0LF5Q
  • ABT 267
  • AC1N4WA5
  • OMBITASVIR [WHO-DD]
  • C50H67N7O8
  • DTXSID201027920
  • SCHEMBL8542284
  • UNII-2302768XJ8
  • CHEMBL3127326
  • OMBITASVIR [ORANGE BOOK]
  • VIEKIRAX COMPONENT OMBITASVIR
  • GTPL11272
  • AMY6935
  • MFCD28386270
  • DTXCID101513481
  • GLXC-07662
  • EX-A5846
  • BDBM50453112
  • EBC-27503
  • s5403
  • 2302768XJ8
  • AKOS025396425
  • ZINC150601177
  • CCG-270561
  • CS-5330
  • DB09296
  • ABT-267;ABT267;ABT 267
  • compound 38 [PMID: 24400777]
  • NCGC00510316-01
  • NCGC00510316-02
  • AO178040
  • CID:54767916
  • DA-56437
  • HY-13997
  • SID:252166943
  • J3.279.162J
  • C72037
  • D10576
  • A856321
  • C586094
  • EN300-20352138
  • Technivie (ombitasvir + paritaprevir + ritonavir)
  • BRD-K11072003-001-01-6
  • Q19598175
  • Viekirax (ombitasvir + paritaprevir + ritonavir; EU)
  • Carbamic acid, N,N'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)bis(4,1-phenyleneiminocarbonyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-, C,C'-dimethyl ester
  • L-Prolinamide,2,2'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)di-4,1-phenylene)bis(N-(methoxycarbonyl)-L-valyl-
  • Methyl ((S)-1-((S)-2-((4-((2S,5S)-1-(4-(tert-butyl)phenyl)-5-(4-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidine-2-carboxamido)phenyl)pyrrolidin-2-yl)phenyl)carbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
  • L-Prolinamide, 2,2'-[[(2S,5S)-1-[4-(1,1-dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl-
  • methyl N-[(2S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
  • dimethyl ([(2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl]bis{(4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl[(2S)-3-methyl-1-oxobutane-1,2-diyl]})biscarbamate
  • methyl N-[(1S)-1-[(2S)-2-[[4-[(2S,5S)-1-(4-tert-butylphenyl)-5-[4-[[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methyl-butanoyl]pyrrolidine-2-carbonyl]amino]phenyl]pyrrolidin-2-yl]phenyl]carbamoyl]pyrrolidine-1-carbonyl]-2-methyl-propyl]carbamate
  • methyl N-[(2S)-1-[(2S)-2-({4-[(2S,5S)-1-(4-tert-butylphenyl)-5-{4-[(2S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methylbutanoyl]pyrrolidine-2-amido]phenyl}pyrrolidin-2-yl]phenyl}carbamoyl)pyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
  • N,N'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)bis(4,1-phenyleneiminocarbonyl-(2S)-2,1-pyrrolidinediyl((1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl)))bis-C,C'-dimethyl ester carbamic acid
  • 1258276-28-6
  • ABT 267; 2,2'-[[(2S,5S)-1-[4-(1,1-Dimethylethyl)phenyl]-2,5-pyrrolidinediyl]di-4,1-phenylene]bis[N-(methoxycarbonyl)-L-valyl-L-prolinamide]
  • ABT 267|||Dimethyl ((2S,2'S)-((2S,2'S)-2,2'-(((((2S,5S)-1-(4-(tert-butyl)phenyl)pyrrolidine-2,5-diyl)bis(4,1-phenylene))bis(azanediyl))bis(carbonyl))bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl))dicarbamate
  • Diindeno[7,1-de:1',7'-fg][1,3,2]dioxaphosphocin, 10,11,12,13-tetrahydro-5-hydroxy-3,7-bis[2,4,6-tris(1-methylethyl)phenyl]-, 5-oxide, (11aS)-
  • dimethyl (((2S,5S)-1-(4-tert-butylphenyl)pyrrolidine-2,5-diyl)bis((4,1-phenylene)carbamoyl(2S)pyrrolidine-2,1-diyl((2S)-3-methyl-1-oxobutane-1,2-diyl)))biscarbamate
  • Dimethyl(2S,2'S)-1,1'-((2S,2'S)-2,2'-(4,4'-((2S,5S)-1-(4-tert-Butylphenyl)pyrrolidine-2,5-diyl)bis(4,1-phenylene))bis-(azanediyl)bis(oxomethylene)bis(pyrrolidine-2,1-diyl))bis(3-methyl-1-oxobutane-2,1-diyl)dicarbamate
  • L-Prolinamide,2,2'-(((2S,5S)-1-(4-(1,1-dimethylethyl)phenyl)-2,5-pyrrolidinediyl)di-4,1-phenylene)bis(N-(methoxycarbonyl)-L-valy
  • methyl N-((2S)-1-((2S)-2-((4-((2S,5S)-1-(4-tert-butylphenyl)-5-(4-(((2S)-1-((2S)-2-(methoxycarbonylamino)-3-methylbutanoyl)pyrrolidine-2-carbonyl)amino)phenyl)pyrrolidin-2-yl)phenyl)carbamoyl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate
  • N,N -[[(2S,5S)-1-(4-tert-Butylphenyl)pyrrolidine-2,5-diyl]bis(1,4-phenylene)]bis[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutyryl]pyrrolidine-2-carboxamide]
  • N,N -[1-(4-tert-Butylphenyl)-2alpha,5beta-pyrrolidinediylbis(1,4-phenylene)]bis[(2S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutyryl]pyrrolidine-2-carboxamide]